Estrogen Years Tied To Stronger Lungs

Gloved hand holding estrogen and testosterone vials — Photo: angellodeco / Shutterstock

Women whose bodies spend more years cycling through periods may end up with healthier lungs decades later, new research suggests.

Story Snapshot

A large study found women with 40 or more reproductive years had a 12% lower risk of bronchiectasis, a chronic lung disease, than women with fewer than 30 years.
The protective link grew stronger, to 22% lower risk, among women who never used hormone therapy.
Earlier research on lung function and lung cancer has pointed in a similar direction, though not every study agrees.
Doctors measure reproductive lifespan by subtracting the age a woman started her period from the age she reached menopause.

What The New Bronchiectasis Study Found

Researchers tracked thousands of women and looked at bronchiectasis, a disease that damages the airways and makes breathing harder over time. Women with 40 or more reproductive years showed a 12% lower risk of developing the disease compared to women with less than 30 years. Among women who skipped hormone therapy altogether, that protective effect jumped to 22%, hinting that natural hormone exposure may matter more than replacement therapy.

The study included roughly 2,600 confirmed cases, giving researchers a solid sample to work with. That size matters because bronchiectasis often gets overlooked next to bigger lung conditions like COPD or cancer. A clear, consistent pattern across thousands of records carries more weight than a handful of scattered case reports.

Earlier Research Backs The Pattern

This isn’t the first time scientists have connected reproductive timing to lung health. A 2015 study of postmenopausal women found that a shorter reproductive lifespan lined up with abnormal lung function, especially a restrictive breathing pattern where the lungs can’t fully expand. That earlier work used the same basic math: subtract age at first period from age at menopause.

Lung cancer research tells a similar story in places. A case-control study found women who reached menopause at 51 or later had nearly half the lung cancer risk of women who went through menopause earlier. A massive UK Biobank study tracking almost 275,000 women found those with reproductive spans of 32 years or less faced a 42% higher risk of new lung cancer diagnoses over 12 years.

Why The Story Isn’t Perfectly Clean

Not every study lines up neatly. One prospective cohort study found no statistically significant link between several reproductive factors and lung cancer risk at all. A pooled analysis from the International Lung Cancer Consortium found breastfeeding cut risk while having children raised it, a mixed result that resists simple headlines.

These differences don’t cancel out the overall pattern, but they do explain why scientists talk about associations rather than proof. The studies measure different things too. Some look at lung function tests, others track bronchiectasis cases, and others follow lung cancer diagnoses. Lumping them together as one story about “lung health” oversimplifies what each study actually measured.

The Hormone Therapy Wrinkle

The bronchiectasis study’s hormone therapy finding deserves its own spotlight. Women who never used hormone therapy saw the strongest protective link between reproductive years and lung health. That doesn’t mean hormone therapy causes lung disease. It likely means the body’s own natural estrogen exposure, sustained over more years, plays a different role than external hormones added later in life.

This distinction matters for women weighing hormone therapy decisions with their doctors. It also matters for how the public reads headlines. A simple claim like “longer reproductive years equal healthier lungs” skips over the subgroup differences that actually make the research interesting and useful.

What Comes Next For This Research

Scientists still need to nail down why this link exists. Estrogen affects inflammation and tissue repair throughout the body, and lungs are no exception. Researchers want to see the full published paper on the bronchiectasis study, including how they controlled for smoking, weight, and income, all factors that can muddy any health link.

Until then, the pattern holds up across multiple studies and disease types, even if the size of the effect shifts from one dataset to the next. Women and their doctors now have one more piece of evidence to weigh when discussing long-term lung health, menopause timing, and hormone therapy choices.